The physiologic basis for anticytokine clinical trials in the treatment of sepsis

被引：49

作者：

Cain, BS ^{[1
]}

Meldrum, DR ^{[1
]}

Harken, AH ^{[1
]}

McIntyre, RC ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 1998年 / 186卷 / 03期

关键词：

D O I：

10.1016/S1072-7515(98)00036-2

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：337 / 350

页数：14

共 163 条

[1] PHOSPHATIDIC-ACID SIGNALING MEDIATES LUNG CYTOKINE EXPRESSION AND LUNG INFLAMMATORY INJURY AFTER HEMORRHAGE IN MICE
ABRAHAM, E
BURSTEN, S
SHENKAR, R
ALLBEE, J
TUDER, R
WOODSON, P
GUIDOT, DM
RICE, G
SINGER, JW
REPINE, JE
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 569 - 575
[2] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL
ABRAHAM, E
WUNDERINK, R
SILVERMAN, H
PERL, TM
NASRAWAY, S
LEVY, H
BONE, R
WENZEL, RP
BALK, R
ALLRED, R
PENNINGTON, JE
WHERRY, JC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12): : 934 - 941
[3] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial
Abraham, E
Glauser, MP
Butler, T
Garbino, J
Gelmont, D
Laterre, PF
Kudsk, K
Bruining, HA
Otto, C
Tobin, E
Zwingelstein, C
Lesslauer, W
Leighton, A
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19): : 1531 - 1538
[4] ABRAHAM E, 1995, 2 ANN AUT SEPS M DEA, P55
[5] ADAMS RD, 1992, ORGANOMETALLICS, V11, P496, DOI 10.1021/om00037a087
[6] A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE
ALEXANDER, HR
DOHERTY, GM
BURESH, CM
VENZON, DJ
NORTON, JA
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) : 1029 - 1032
[7] INDUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA IN MURINE CANDIDA-ALBICANS INFECTION
ALLENDOERFER, R
MAGEE, DM
SMITH, JG
BONEWALD, L
GRAYBILL, JR
[J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (05) : 1168 - 1172
[8] Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: Biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage
Amiot, F
Boussadia, O
Cases, S
Fitting, C
Lebastard, M
Cavaillon, JM
Milon, G
Dautry, F
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) : 1035 - 1042
[9] INTERLEUKIN-1 RECEPTOR ANTAGONIST
AREND, WP
[J]. ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 : 167 - 227
[10] DIVERGENT EFFICACY OF ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN INTRAVASCULAR AND PERITONITIS MODELS OF SEPSIS
BAGBY, GJ
PLESSALA, KJ
WILSON, LA
THOMPSON, JJ
NELSON, S
[J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) : 83 - 88

← 1 2 3 4 5 6 7 8 9 10 →